Insider · CIK 0002011733
Victor J. Sordillo
Files at TVGN (Tevogen Bio Holdings Inc.). First filing -, latest -.
In brief
Victor J. Sordillo files SEC Form 4 as director at TVGN (Tevogen Bio Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Victor J. Sordillo has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 126,539 | 28 d ago |
| Jul 10, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 51,539 | Jul 10, 2026 |
| Dec 23, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 336,962 | Dec 26, 2024 |
| Dec 23, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 576,962 | Dec 26, 2024 |
Questions about Victor J. Sordillo
Answered from the filings on this page, as of the latest one.
Is Victor J. Sordillo buying or selling?
Victor J. Sordillo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Victor J. Sordillo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Victor J. Sordillo has 0.
Where does Victor J. Sordillo file Form 4?
Victor J. Sordillo has filed Form 4 at TVGN (Tevogen Bio Holdings Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.